Healthcare provider profile · identity verified

Gary Sobelson, MD

Family Practice · CONCORD, NH · NPI 1699722926

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	215	51
Levothyroxine Sodium	Levothyroxine Sodium	205	39
Hydrochlorothiazide	Hydrochlorothiazide	176	44
Simvastatin	Simvastatin	164	42
Lisinopril	Lisinopril	149	37
Amlodipine Besylate	Amlodipine Besylate	125	33
Atenolol	Atenolol	124	35
Metoprolol Succinate	Metoprolol Succinate	119	29
Omeprazole	Omeprazole	110	31
Losartan Potassium	Losartan Potassium	98	23
Gabapentin	Gabapentin	97	20
Metformin Hcl	Metformin Hcl	93	26
Tamsulosin Hcl	Tamsulosin Hcl	79	14
Metoprolol Tartrate	Metoprolol Tartrate	78	17
Potassium Chloride	Potassium Chloride	70	18
Eliquis	Apixaban	68	14
Furosemide	Furosemide	68	suppressed
Trazodone Hcl	Trazodone Hcl	65	14
Enalapril Maleate	Enalapril Maleate	55	13
Sertraline Hcl	Sertraline Hcl	55	13
Allopurinol	Allopurinol	52	13
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Famotidine	Famotidine	48	14
Pantoprazole Sodium	Pantoprazole Sodium	48	suppressed
Prednisone	Prednisone	48	17
Glipizide	Glipizide	47	11
Rosuvastatin Calcium	Rosuvastatin Calcium	46	11
Fluticasone Propionate	Fluticasone Propionate	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	11
Alprazolam	Alprazolam	32	12
Benazepril Hcl	Benazepril Hcl	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	12
Finasteride	Finasteride	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	12
Estradiol	Estradiol	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Naproxen	Naproxen	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Cephalexin	Cephalexin	23	13
Glipizide Er	Glipizide	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Rivastigmine	Rivastigmine Tartrate	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	11
Clonidine Hcl	Clonidine Hcl	18	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	11
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Ozempic	Semaglutide	16	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Baclofen	Baclofen	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Trospium Chloride	Trospium Chloride	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Captopril	Captopril	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Olanzapine	Olanzapine	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error